Cargando…

Young patients with cancer and a digital social network: the voice beyond the clinic

INTRODUCTION: Digital social networks have become a key player in the ecosystem of young patients with cancer, with regard to their unique perspectives and unmet needs. This study aims to investigate the web-based social community tools and to characterise the user profile, unmet needs and goals of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Aharon, Irit, Goshen-Lago, Tal, Turgeman, Ilit, Fontana, Elisa, Smyth, Elizabeth, Lordick, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228558/
https://www.ncbi.nlm.nih.gov/pubmed/32385087
http://dx.doi.org/10.1136/esmoopen-2019-000651
_version_ 1783534610867552256
author Ben-Aharon, Irit
Goshen-Lago, Tal
Turgeman, Ilit
Fontana, Elisa
Smyth, Elizabeth
Lordick, Florian
author_facet Ben-Aharon, Irit
Goshen-Lago, Tal
Turgeman, Ilit
Fontana, Elisa
Smyth, Elizabeth
Lordick, Florian
author_sort Ben-Aharon, Irit
collection PubMed
description INTRODUCTION: Digital social networks have become a key player in the ecosystem of young patients with cancer, with regard to their unique perspectives and unmet needs. This study aims to investigate the web-based social community tools and to characterise the user profile, unmet needs and goals of young patients with cancer. METHODS: A web-based survey was distributed via large-scale social network designated for young patients with cancer (age 18–45 years) Stop Cancer. The survey collected demographic data and oncological status. Primary outcome was potential goals of accessing the network; secondary outcomes were emotional impact, effect of disease status, education, marital status and employment, on user satisfaction rate. RESULTS: The survey was available for 5 days (10/2018) and was filled by 523 participants. Breast cancer, haematological malignancies and colorectal cancer were the most common diagnoses. The majority had non-metastatic disease at diagnosis, 79% had no evidence of disease at time of the survey. Forty-five per cent considered the network as a reliable source for medical information. Academic education was associated with higher satisfaction from the platform. There were no differences between cancer survivors and patients with active disease in patterns of platform usage. The social network had an allocated section for ‘patient mentoring’ of newly diagnosed members by survivors. DISCUSSION: Our study portrayed the user prototype of a social digital network among young adult patients with cancer, indicating challenging trends. Whereas social media may prove a powerful tool for patients and physicians alike, it may also serve as a research tool to appraise wide practices within a heterogeneous population. Nevertheless, it acts as a double-edged sword in the setting of uncontrolled medical information. It is our role as healthcare providers to join this race and play an active role in shaping its medical perspectives.
format Online
Article
Text
id pubmed-7228558
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72285582020-05-18 Young patients with cancer and a digital social network: the voice beyond the clinic Ben-Aharon, Irit Goshen-Lago, Tal Turgeman, Ilit Fontana, Elisa Smyth, Elizabeth Lordick, Florian ESMO Open Original Research INTRODUCTION: Digital social networks have become a key player in the ecosystem of young patients with cancer, with regard to their unique perspectives and unmet needs. This study aims to investigate the web-based social community tools and to characterise the user profile, unmet needs and goals of young patients with cancer. METHODS: A web-based survey was distributed via large-scale social network designated for young patients with cancer (age 18–45 years) Stop Cancer. The survey collected demographic data and oncological status. Primary outcome was potential goals of accessing the network; secondary outcomes were emotional impact, effect of disease status, education, marital status and employment, on user satisfaction rate. RESULTS: The survey was available for 5 days (10/2018) and was filled by 523 participants. Breast cancer, haematological malignancies and colorectal cancer were the most common diagnoses. The majority had non-metastatic disease at diagnosis, 79% had no evidence of disease at time of the survey. Forty-five per cent considered the network as a reliable source for medical information. Academic education was associated with higher satisfaction from the platform. There were no differences between cancer survivors and patients with active disease in patterns of platform usage. The social network had an allocated section for ‘patient mentoring’ of newly diagnosed members by survivors. DISCUSSION: Our study portrayed the user prototype of a social digital network among young adult patients with cancer, indicating challenging trends. Whereas social media may prove a powerful tool for patients and physicians alike, it may also serve as a research tool to appraise wide practices within a heterogeneous population. Nevertheless, it acts as a double-edged sword in the setting of uncontrolled medical information. It is our role as healthcare providers to join this race and play an active role in shaping its medical perspectives. BMJ Publishing Group 2020-05-07 /pmc/articles/PMC7228558/ /pubmed/32385087 http://dx.doi.org/10.1136/esmoopen-2019-000651 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Ben-Aharon, Irit
Goshen-Lago, Tal
Turgeman, Ilit
Fontana, Elisa
Smyth, Elizabeth
Lordick, Florian
Young patients with cancer and a digital social network: the voice beyond the clinic
title Young patients with cancer and a digital social network: the voice beyond the clinic
title_full Young patients with cancer and a digital social network: the voice beyond the clinic
title_fullStr Young patients with cancer and a digital social network: the voice beyond the clinic
title_full_unstemmed Young patients with cancer and a digital social network: the voice beyond the clinic
title_short Young patients with cancer and a digital social network: the voice beyond the clinic
title_sort young patients with cancer and a digital social network: the voice beyond the clinic
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228558/
https://www.ncbi.nlm.nih.gov/pubmed/32385087
http://dx.doi.org/10.1136/esmoopen-2019-000651
work_keys_str_mv AT benaharonirit youngpatientswithcancerandadigitalsocialnetworkthevoicebeyondtheclinic
AT goshenlagotal youngpatientswithcancerandadigitalsocialnetworkthevoicebeyondtheclinic
AT turgemanilit youngpatientswithcancerandadigitalsocialnetworkthevoicebeyondtheclinic
AT fontanaelisa youngpatientswithcancerandadigitalsocialnetworkthevoicebeyondtheclinic
AT smythelizabeth youngpatientswithcancerandadigitalsocialnetworkthevoicebeyondtheclinic
AT lordickflorian youngpatientswithcancerandadigitalsocialnetworkthevoicebeyondtheclinic